Trial intelligence / Profile preview

Tranexamic Acid in Periacetabular Osteotomy

NCT02253810Completed

Sponsor
Hospital for Special Surgery
Start
Oct 2014
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in hip dysplasia (DDH) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Calculated Total Blood Loss at 1 day. Started Oct 2014; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hip dysplasia (DDH)

Beyond the preview

Go deeper on NCT02253810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02253810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call